Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2018

01-10-2018 | Editorial

Compromise of α-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia

Author: Kanakaraju Kaliannan

Published in: Digestive Diseases and Sciences | Issue 10/2018

Login to get access

Excerpt

Innate and adaptive immune dysfunction, also referred to as cirrhosis-associated immune dysfunction syndrome (CAIDS), is a major component of liver cirrhosis (LC), substantially contributing to the pathogenesis of the acute and chronic deterioration of liver function [1]. In advanced LC with CAID, small intestinal bacterial overgrowth (SIBO) and increased intestinal permeability (IP) are frequent findings linked to the translocation of bacteria and bacterial components such as endotoxin (lipopolysaccharide; LPS) from gut lumen to the systemic circulation, termed bacterial translocation (BT) [2]. BT is presumed to be the major mechanism leading to the development of spontaneous infections in liver cirrhosis, occurring in up to 30% of patients with decompensated LC, associated with a high mortality [3]. Despite the significant clinical burden, the precise underlying cellular and molecular pathways implicated in the phenomenon of BT in LC have not yet been studied. …
Literature
2.
go back to reference Ponziani FR, Zocco MA, Cerrito L, et al. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641–656.CrossRefPubMed Ponziani FR, Zocco MA, Cerrito L, et al. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641–656.CrossRefPubMed
3.
go back to reference Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34:32–37.CrossRefPubMed Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001;34:32–37.CrossRefPubMed
4.
go back to reference Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.CrossRefPubMed Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.CrossRefPubMed
5.
go back to reference Nouri-Aria KT, Alexander GJ, Portmann BC, et al. T and B cell function in alcoholic liver disease. J Hepatol. 1986;2:195–207.CrossRefPubMed Nouri-Aria KT, Alexander GJ, Portmann BC, et al. T and B cell function in alcoholic liver disease. J Hepatol. 1986;2:195–207.CrossRefPubMed
6.
go back to reference Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003;422:522–526.CrossRefPubMed Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003;422:522–526.CrossRefPubMed
7.
go back to reference Teltschik Z, Wiest R, Beisner J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology. 2012;55:1154–1163.CrossRefPubMed Teltschik Z, Wiest R, Beisner J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology. 2012;55:1154–1163.CrossRefPubMed
8.
go back to reference Tsiaoussis GI, Papaioannou EC, Kourea EP, et al. Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-018-5146-9. Tsiaoussis GI, Papaioannou EC, Kourea EP, et al. Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function. Dig Dis Sci. (Epub ahead of print). https://​doi.​org/​10.​1007/​s10620-018-5146-9.
9.
go back to reference Choudhry MA, Fazal N, Goto M, et al. Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am J Physiol Gastrointest Liver Physiol. 2002;282:G937–G947.CrossRefPubMed Choudhry MA, Fazal N, Goto M, et al. Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am J Physiol Gastrointest Liver Physiol. 2002;282:G937–G947.CrossRefPubMed
10.
go back to reference Larsen R, Mertz-Nielsen A, Hansen MB, et al. Novel modified Ussing chamber for the study of absorption and secretion in human endoscopic biopsies. Acta Physiol Scand. 2001;173:213–222.CrossRefPubMed Larsen R, Mertz-Nielsen A, Hansen MB, et al. Novel modified Ussing chamber for the study of absorption and secretion in human endoscopic biopsies. Acta Physiol Scand. 2001;173:213–222.CrossRefPubMed
11.
go back to reference Kaliannan K, Wang B, Li XY, et al. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep. 2015;5:11276.CrossRefPubMedPubMedCentral Kaliannan K, Wang B, Li XY, et al. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep. 2015;5:11276.CrossRefPubMedPubMedCentral
Metadata
Title
Compromise of α-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia
Author
Kanakaraju Kaliannan
Publication date
01-10-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5197-y

Other articles of this Issue 10/2018

Digestive Diseases and Sciences 10/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.